Briaud Financial Planning’s Organon & Co OGN Stock Holding History

Briaud Financial Planning’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	–	–	115
2023 Q3	$0	Buy	+3	New	+$63	﹤0.01%	169

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Briaud Financial Planning's OGN Position: Q4 2023 in Review

Briaud Financial Planning sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 3 shares.

Briaud Financial Planning first reported a position in OGN in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 718 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Briaud Financial Planning reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Briaud Financial Planning sold 3 Organon & Co shares in Q4 2023.
Briaud Financial Planning first reported a position in Organon & Co in Q3 2023 and held it in 1 quarter.
Briaud Financial Planning's Organon & Co position peaked at $0 in Q3 2023.
718 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Briaud Financial Planning's 13F filing for Q4 2023, filed 2 Feb 2024.